Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Terminated × Gastrointestinal Toxicity × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1 Gastrointestinal 1

Conditions

Breast Neoplasms 188 Neoplasms 148 Prostatic Neoplasms 101 Lung Neoplasms 88 Carcinoma, Non-Small-Cell Lung 59 Colorectal Neoplasms 57 Head and Neck Neoplasms 53 Pancreatic Neoplasms 45 Carcinoma, Hepatocellular 43 Brain Neoplasms 41 Rectal Neoplasms 40 Multiple Myeloma 38 Colonic Neoplasms 37 Esophageal Neoplasms 34 Precursor Cell Lymphoblastic Leukemia-Lymphoma 30 Neoplasm Metastasis 30 Leukemia, Myeloid, Acute 29 Leukemia 29 Ovarian Neoplasms 28 Lymphoma, Non-Hodgkin 28 Lymphoma 28 Motor Activity 24 Hodgkin Disease 24 Uterine Cervical Neoplasms 23 Pain 22 Carcinoma, Renal Cell 22 Glioma 21 Depression 21 Lymphoma, Follicular 20 Leukemia, Lymphocytic, Chronic, B-Cell 20

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02351089 2020-03-05

ProRad

Probi AB

Phase NA Terminated

GastrointestinalGynecologic

Gastrointestinal Toxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡